Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Poly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide-Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin C.
Giansanti M, De Gabrieli A, Prete SP, Ottone T, Divona MD, Karimi T, Ciccarone F, Voso MT, Graziani G, Faraoni I. Giansanti M, et al. Among authors: divona md. J Pharmacol Exp Ther. 2021 Jun;377(3):385-397. doi: 10.1124/jpet.121.000537. Epub 2021 Apr 5. J Pharmacol Exp Ther. 2021. PMID: 33820831
Acute myeloid leukemia with paraneoplastic pemphigus successfully treated with a personalized antileukemic and immunosuppressive strategy.
Iovene FR, Santinelli E, Armiento D, Sarlo C, Bancone C, Silvestri L, Erculei S, Sanhust MG, Cristiano A, Fabiani E, Divona M, Page C, Di Zenzo G, Cantonetti M, Rigacci L. Iovene FR, et al. Among authors: divona m. Ann Hematol. 2024 May 23. doi: 10.1007/s00277-024-05804-x. Online ahead of print. Ann Hematol. 2024. PMID: 38780802
Given the rarity and severity of both conditions, our treatment strategy aimed to maximize efficacy by combining immunosuppressive therapy (initially plasmapheresis with high-dose corticosteroids, followed by anti-CD20 monoclonal antibody and intravenous immunoglobulins 2 g/m …
Given the rarity and severity of both conditions, our treatment strategy aimed to maximize efficacy by combining immunosuppressive therapy ( …